Definitive Healthcare (DH) EBIAT (2020 - 2025)
Definitive Healthcare (DH) has disclosed EBIAT for 6 consecutive years, with -$9.3 million as the latest value for Q4 2025.
- For the quarter ending Q4 2025, EBIAT rose 96.08% year-over-year to -$9.3 million, compared with a TTM value of -$138.9 million through Dec 2025, up 76.51%, and an annual FY2025 reading of -$138.9 million, up 76.51% over the prior year.
- EBIAT was -$9.3 million for Q4 2025 at Definitive Healthcare, down from $34.7 million in the prior quarter.
- Across five years, EBIAT topped out at $34.7 million in Q3 2025 and bottomed at -$306.2 million in Q2 2024.
- Average EBIAT over 5 years is -$52.2 million, with a median of -$12.7 million recorded in 2024.
- The sharpest move saw EBIAT surged 331.64% in 2022, then tumbled 2538.41% in 2024.
- Year by year, EBIAT stood at -$9.9 million in 2021, then soared by 331.64% to $22.8 million in 2022, then plummeted by 158.49% to -$13.4 million in 2023, then tumbled by 1676.66% to -$237.4 million in 2024, then skyrocketed by 96.08% to -$9.3 million in 2025.
- Business Quant data shows EBIAT for DH at -$9.3 million in Q4 2025, $34.7 million in Q3 2025, and -$9.3 million in Q2 2025.